The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.

Abstract:

:The c-Fes protein-tyrosine kinase exhibits strong expression in myeloid hematopoietic cells. Previous studies have shown that Fes induces differentiation in the chronic myelogenous leukemia-derived cell line K-562, suggesting that the Fes signal for differentiation is dominant to the Bcr-Abl signal for transformation in these cells. In addition, Fes has been shown to associate with and phosphorylate Bcr on NH2-terminal sequences retained within Bcr-Abl. To determine whether Fes interacts directly with Bcr-Abl, kinase-inactive Bcr-Abl was coexpressed with Fes in 293T cells, and phosphorylation was assessed by anti-phosphotyrosine immunoblotting. Bcr-Abl was strongly phosphorylated by Fes under these conditions, suggestive of direct interaction. Similarly, tyrosine phosphorylation of kinase-inactive Fes was observed after coexpression with active Bcr-Abl. To test for the interaction of Fes with Bcr-Abl under physiological conditions, wild-type and kinase-defective Fes were stably expressed in the cytokine-dependent myeloid leukemia cell line, DAGM. Expression of either form of Fes alone did not affect the proliferation or interleukin 3 dependence of these cells. The DAGM/Fes cells were then infected with Bcr-Abl retroviruses, and their rates of cytokine-independent outgrowth were compared. Fes dramatically suppressed Bcr-Abl-induced DAGM cell outgrowth relative to a cell line expressing beta-galactosidase as a negative control. This effect required Fes tyrosine kinase activity, because the kinase-inactive form of Fes did not affect Bcr-Abl-induced cell outgrowth. The phosphotyrosine content of both wild-type and kinase-inactive Fes was strongly enhanced after coexpression with Bcr-Abl in DAGM cells, similar to the 293T result. Phosphorylation of wild-type Fes correlated with stimulation of Fes tyrosine kinase activity in the presence of Bcr-Abl. These results show that Fes and Bcr-Abl interact in myeloid cells, leading to Fes activation and suppression of Bcr-Abl-induced conversion to cytokine independence.

journal_name

Cancer Res

journal_title

Cancer research

authors

Lionberger JM,Smithgall TE

subject

Has Abstract

pub_date

2000-02-15 00:00:00

pages

1097-103

issue

4

eissn

0008-5472

issn

1538-7445

journal_volume

60

pub_type

杂志文章
  • Cyclin D1 activity regulates autophagy and senescence in the mammary epithelium.

    abstract::Overexpression of cyclin D1 is believed to endow mammary epithelial cells (MEC) with a proliferative advantage by virtue of its contribution to pRB inactivation. Accordingly, abrogation of the kinase-dependent function of cyclin D1 is sufficient to render mice resistant to breast cancer initiated by ErbB2. Here, we re...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-4139

    authors: Brown NE,Jeselsohn R,Bihani T,Hu MG,Foltopoulou P,Kuperwasser C,Hinds PW

    更新日期:2012-12-15 00:00:00

  • Differential cell photosensitivity following porphyrin photodynamic therapy.

    abstract::Experiments were performed to determine if differences in porphyrin photosensitivity could be observed for cells with varying efficiency in DNA damage repair, as well as for cells which make up components of the vasculature. Photofrin II is undergoing current clinical evaluation for photodynamic therapy of solid tumor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gomer CJ,Rucker N,Murphree AL

    更新日期:1988-08-15 00:00:00

  • Regulation of carbonyl-reducing enzymes in rat liver by chemoprotectors.

    abstract::Feeding rats on diets containing the synthetic antioxidants ethoxyquin, butylated hydroxyanisole, and oltipraz results in 15-, 9-, and 6-fold increases, respectively, in the hepatic levels of aflatoxin B1-dialdehyde reductase (AFAR) protein. By contrast, treatment of rats with either of the inducing agents phenobarbit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ellis EM,Judah DJ,Neal GE,O'Connor T,Hayes JD

    更新日期:1996-06-15 00:00:00

  • An exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data.

    abstract::The data of nine monolayer cultures, 48 multicellular spheroids, and 19 s.c. xenografts of LoVo cells were fitted, on an individual basis, by exponential and Gompertzian equations, respectively. The mean growth parameters alpha 0 (initial growth rate) and beta (retardation factor) of the three experimental systems pre...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Demicheli R,Foroni R,Ingrosso A,Pratesi G,Soranzo C,Tortoreto M

    更新日期:1989-12-01 00:00:00

  • Identification and characterization of the insulin receptor in the R3230AC mammary adenocarcinoma of the rat.

    abstract::The binding of labeled insulin to dissociated R3230AC mammary adenocarcinoma cells from diabetic and intact rats was investigated in vitro. At 20 degrees, specific binding (total binding minus binding in the presence of 1000-fold excess or 10(-6) M unlabeled insulin) reached a plateau at 45 to 60 min and was directly ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Harmon JT,Hilf R

    更新日期:1976-11-01 00:00:00

  • The ribonucleoside diphosphate reductase inhibitor (E)-2'-deoxy-(fluoromethylene)cytidine as a cytotoxic radiosensitizer in vitro.

    abstract::(E)-2'-Deoxy-(fluoromethylene)cytidine (FMdC) is known as an inhibitor of ribonucleoside diphosphate reductase, a key enzyme in the de novo pathway of DNA synthesis. FMdC was tested as a modifier of radiation response in vitro on a human colon carcinoma cell line (WiDr), and the observed radiosensitization was confirm...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Coucke PA,Decosterd LA,Li YX,Cottin E,Chen X,Sun LQ,Stern S,Paschoud N,Denekamp J

    更新日期:1999-10-15 00:00:00

  • NEDD9 promotes oncogenic signaling in mammary tumor development.

    abstract::In the past 3 years, altered expression of the HEF1/CAS-L/NEDD9 scaffolding protein has emerged as contributing to cancer metastasis in multiple cancer types. However, whereas some studies have identified elevated NEDD9 expression as prometastatic, other work has suggested a negative role in tumor progression. We here...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0795

    authors: Izumchenko E,Singh MK,Plotnikova OV,Tikhmyanova N,Little JL,Serebriiskii IG,Seo S,Kurokawa M,Egleston BL,Klein-Szanto A,Pugacheva EN,Hardy RR,Wolfson M,Connolly DC,Golemis EA

    更新日期:2009-09-15 00:00:00

  • MUC1 in macrophage: contributions to cigarette smoke-induced lung cancer.

    abstract::Expression of the pro-oncogenic mucin MUC1 is elevated by inflammation in airway epithelial cells, but the contributions of MUC1 to the development of lung cancer are uncertain. In this study, we developed our finding that cigarette smoke increases Muc1 expression in mouse lung macrophages, where we hypothesized MUC1 ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1713

    authors: Xu X,Padilla MT,Li B,Wells A,Kato K,Tellez C,Belinsky SA,Kim KC,Lin Y

    更新日期:2014-01-15 00:00:00

  • Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.

    abstract::The role of hereditary polymorphisms of the arylamine N-acetyltransferase 1 (NAT1) gene in the etiology of urinary bladder cancer is controversial. NAT1 is expressed in the urothelium and may O-acetylate hydroxyl amines, particularly in subjects with low NAT2 activity. Thus, NAT1 polymorphisms may affect the individua...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cascorbi I,Roots I,Brockmöller J

    更新日期:2001-07-01 00:00:00

  • SAS amplification in soft tissue sarcomas.

    abstract::Gene amplification is an important mechanism of increased gene expression in a number of human solid tumors. We have recently identified and cloned sequences from a novel DNA amplification unit in malignant fibrous histiocytoma. The amplified sequences are derived from chromosome 12q13-14 and encode a gene designated ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Smith SH,Weiss SW,Jankowski SA,Coccia MA,Meltzer PS

    更新日期:1992-07-01 00:00:00

  • Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy.

    abstract::Liposome formulations of camptothecins have been actively pursued because of the potential for significant pharmacologic advantages from successful drug delivery of this important class of anticancer drugs. We describe nanoliposomal CPT-11, a novel nanoparticle/liposome construct containing CPT-11 (irinotecan) with un...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-4007

    authors: Drummond DC,Noble CO,Guo Z,Hong K,Park JW,Kirpotin DB

    更新日期:2006-03-15 00:00:00

  • Metastatic growth progression caused by PSGL-1-mediated recruitment of monocytes to metastatic sites.

    abstract::Tumor cell-derived selectin ligands mediate contact to the endothelium, platelets, and leukocytes through binding to selectins that facilitates metastasis. Here, we describe the mechanism of how endogenous (non-tumor derived) selectin ligands contribute to metastasis using α(1,3)fucosyltransferase 7 (Fuc-TVII(-/-))-de...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0946

    authors: Hoos A,Protsyuk D,Borsig L

    更新日期:2014-02-01 00:00:00

  • P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response.

    abstract::Despite studies that show the antitumor activity of Hsp90 inhibitors, such as geldanamycin (GA) and its derivative 17-allylamino-demethoxygeldanamycin (17-AAG), recent reports indicate that these inhibitors lack significant single-agent clinical activity. Resistance to Hsp90 inhibitors has been previously linked to ex...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5175

    authors: McCollum AK,TenEyck CJ,Stensgard B,Morlan BW,Ballman KV,Jenkins RB,Toft DO,Erlichman C

    更新日期:2008-09-15 00:00:00

  • Indibulin, a novel microtubule inhibitor, discriminates between mature neuronal and nonneuronal tubulin.

    abstract::Microtubule inhibitors interfere with microtubule dynamics, causing cell cycle arrest and apoptosis. These effects are responsible for the chemotherapeutic activities of members of the taxane and Vinca alkaloid families in oncology. Unfortunately, a major side effect of the taxanes and Vinca alkaloids is the developme...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1342

    authors: Wienecke A,Bacher G

    更新日期:2009-01-01 00:00:00

  • Tropomodulin 1 expression driven by NF-κB enhances breast cancer growth.

    abstract::Triple-negative breast cancers (TNBC), which include the basal-like and claudin-low disease subtypes, are aggressive malignancies for which effective therapeutic targets are lacking. NF-κB activation has an established role in breast malignancy, and it is higher in TNBC than other breast cancer subtypes. On this basis...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3455

    authors: Ito-Kureha T,Koshikawa N,Yamamoto M,Semba K,Yamaguchi N,Yamamoto T,Seiki M,Inoue J

    更新日期:2015-01-01 00:00:00

  • Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.

    abstract::This study investigates whether and to what extent cyclooxygenase type-2 (COX-2) and inducible nitric oxide-synthase (iNOS), both known to have an immunosuppressive effect, are expressed in human ovarian tumors. Because COX-2 and iNOS can be expressed by activated macrophages, the presence of tumor-associated macropha...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Klimp AH,Hollema H,Kempinga C,van der Zee AG,de Vries EG,Daemen T

    更新日期:2001-10-01 00:00:00

  • Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells.

    abstract::A novel matrix-degrading enzyme was identified from human breast cancer cells. This enzyme appears as major gelatinase in hormone-dependent breast cancer cell lines and has as an apparent molecular mass of 80 kDa on gelatin zymography. The 80-kDa enzyme has a unique metal ion specificity. In addition to calcium ions, ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shi YE,Torri J,Yieh L,Wellstein A,Lippman ME,Dickson RB

    更新日期:1993-03-15 00:00:00

  • BET Inhibition Overcomes Receptor Tyrosine Kinase-Mediated Cetuximab Resistance in HNSCC.

    abstract::Cetuximab, the FDA-approved anti-EGFR antibody for head and neck squamous cell carcinoma (HNSCC), has displayed limited efficacy due to the emergence of intrinsic and acquired resistance. We and others have demonstrated that cetuximab resistance in HNSCC is driven by alternative receptor tyrosine kinases (RTK), includ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-0459

    authors: Leonard B,Brand TM,O'Keefe RA,Lee ED,Zeng Y,Kemmer JD,Li H,Grandis JR,Bhola NE

    更新日期:2018-08-01 00:00:00

  • Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.

    abstract::The interleukin (IL)-13 receptor alpha2 (IL-13Ralpha2) chain is a primary binding and internalization subunit for a Th2-derived immune regulatory cytokine, IL-13. Although extremely high levels of IL-13Ralpha2 chain are expressed on a variety of human tumor cells and specimens, its precise role in tumor immunology has...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1265

    authors: Kawakami K,Terabe M,Kawakami M,Berzofsky JA,Puri RK

    更新日期:2006-04-15 00:00:00

  • Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.

    abstract::Transforming growth factor beta-1 (TGF-beta1) is a potent inhibitor of hepatocyte growth both in vivo and in vitro. In this study, we analyzed the effects of TGF-beta1 on both naturally occurring and diethylnitrosamine-induced hepatocarcinogenesis using single transgenic TGF-beta1 and double transgenic c-myc/TGF-beta1...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Factor VM,Kao CY,Santoni-Rugiu E,Woitach JT,Jensen MR,Thorgeirsson SS

    更新日期:1997-06-01 00:00:00

  • A diphtheria toxin-epidermal growth factor fusion protein is cytotoxic to human glioblastoma multiforme cells.

    abstract::The cytotoxicity of a diphtheria toxin-human epidermal growth factor fusion protein (DAB(389)EGF) was tested against 14 human glioma cell lines. After cells were cultured for 48 h with various concentrations of DAB(389)EGF, the percentage reduction in thymidine incorporation was determined. For 13 of 14 cell lines, po...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Liu TF,Cohen KA,Ramage JG,Willingham MC,Thorburn AM,Frankel AE

    更新日期:2003-04-15 00:00:00

  • Induction of pituitary tumors in germ-free rats exposed to Aspergillus versicolor.

    abstract::We clarified the role of mold exposure in pituitary tumor induction using 53 germ-free Wistar rats exposed before birth and continually exposed thereafter, to Aspergillus versicolor alone. Rats were autopsied at 540 to 730 days. Untreated germ-free controls were autopsied on day 730. Thirty-three of the 53 monoassocia...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sumi Y,Nagura H,Miyakawa M

    更新日期:1990-01-15 00:00:00

  • Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.

    abstract::The expression of the mucin-bound sialyl-Lewisx epitope is increased in the tissue of most colorectal carcinomas and in the sera of about 30% of tumor patients. In colon cancer, a portion of the sialyl-Lex groups detectable with the monoclonal antibody AM-3 is located on MUC1 (C. Hanski et al., Cancer Res., 53: 4082-4...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hanski C,Hanski ML,Zimmer T,Ogorek D,Devine P,Riecken EO

    更新日期:1995-02-15 00:00:00

  • Tumor-associated membrane sialoglycoprotein on human small cell lung carcinoma identified by the IgG2a monoclonal antibody SWA20.

    abstract::A mouse IgG2a monoclonal antibody, SWA20, defining a tumor-associated cell surface antigen on small cell carcinoma of the lung (SCC) was generated. The reactivity of the antibody with cell lines was examined by indirect immunofluorescence staining and solid phase radioimmunoassay and the reactivity with tissues by imm...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Waibel R,O'Hara CJ,Smith A,Stahel RA

    更新日期:1988-08-01 00:00:00

  • Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients.

    abstract::Combination of chemotherapy and immunotherapy to increase the effectiveness of an antitumor immune response is currently regarded as an attractive antitumor strategy. In a pilot clinical trial, we have recently documented an increase of melanoma antigen A (Melan-A)-specific, tumor-reactive, long-lasting effector-memor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1326

    authors: Palermo B,Del Bello D,Sottini A,Serana F,Ghidini C,Gualtieri N,Ferraresi V,Catricalà C,Belardelli F,Proietti E,Natali PG,Imberti L,Nisticò P

    更新日期:2010-09-15 00:00:00

  • Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells.

    abstract::Mounting evidence suggests a role for matrix metalloproteinase (MMP)-2 in the malignant progression of breast cancer cells. We showed previously that H-Ras, but not N-Ras, induced invasion of MCF10A human breast epithelial cells through Rac-MKK3/6-p38 pathway resulted in MMP-2 up-regulation. Activation of p38 pathway ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1461

    authors: Song H,Ki SH,Kim SG,Moon A

    更新日期:2006-11-01 00:00:00

  • Long Noncoding RNA DRAIC Inhibits Prostate Cancer Progression by Interacting with IKK to Inhibit NF-κB Activation.

    abstract::DRAIC is a 1.7 kb spliced long noncoding RNA downregulated in castration-resistant advanced prostate cancer. Decreased DRAIC expression predicts poor patient outcome in prostate and seven other cancers, while increased DRAIC represses growth of xenografted tumors. Here, we show that cancers with decreased DRAIC expres...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-3460

    authors: Saha S,Kiran M,Kuscu C,Chatrath A,Wotton D,Mayo MW,Dutta A

    更新日期:2020-03-01 00:00:00

  • Dose-response study with N-nitrosomorpholine in drinking water of F-344 rats.

    abstract::A dose-response study in carcinogenesis was carried out with N-nitrosomorpholine in female F344 rats. The compound was administered in drinking water, which was supplied in controlled amounts of 20 ml per day per rat, 5 days a wk. At the two highest dose rates, 100 mg/liter and 40 mg/liter, treatment lasted 25 and 40 ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lijinsky W,Kovatch RM,Riggs CW,Walters PT

    更新日期:1988-04-15 00:00:00

  • Use of screening phase data to evaluate observer variation of sputum cytodiagnosis as an outcome measure in a chemoprevention trial.

    abstract::Sputum samples obtained during the screening phase of a chemoprevention trial in heavy smokers were evaluated independently by trained cytotechnologists and classified for degree of cellular atypia according to the method of Saccommano et al. (G. Saccommano et al., Cancer (Phila.), 33: 256-270, 1974). The level of agr...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Browman GP,Arnold A,Levine MN,D'Souza T,Turner-Smith LM,Cayco R,Johnstone B,Birse R

    更新日期:1990-02-15 00:00:00

  • Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.

    abstract::A subset of aggressive colorectal cancers exhibit BRAF mutation, MLH1 methylation, and a CpG island methylator phenotype (CIMP), but precursors are poorly established. In this study, we determined the status of these markers in colorectal polyps and evaluated associated risk factors. The study included 771 polyp cases...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-3462

    authors: Burnett-Hartman AN,Newcomb PA,Potter JD,Passarelli MN,Phipps AI,Wurscher MA,Grady WM,Zhu LC,Upton MP,Makar KW

    更新日期:2013-05-01 00:00:00